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Cancer cells are produced by the accumulation of genetic alterations in somatic cells. Those
genetic alterations are produced by xenobiotics, which enter the human body from the
environment, and by autobiotics, which are produced in the human body. Food contains many
different types of xenobiotic mutagens/carcinogens and tumor promoters. Food can influence the
formation of autobiotic mutagens/carcinogens and give rise to tumor-promoting conditions. In
spite of this, it can also contain many antimutagenic, anticarcinogenic, and antitumor-promoting
substances. Carcinogenic risk and anticarcinogenic efficacy are hard to express quantitatively;
however, holistic approaches that are designed to improve lifestyle are realistic for cancer
prevention. Environ Health Perspect 104(Suppl 3):429-433 (1996)
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Cancer as a Genetic Disease
Cancer is now generally regarded as a
disease caused by accumulated alterations
of genes in somatic cells. The involved
genes are related to the classical cancer
phenotype in that they are responsible for
control ofthe cell cycle, growth, differenti-
ation, cellular and structural atypisms, and
ability ofcells to infiltrate into surrounding
tissues or metastasize to distant sites. Genes
that regulate scheduled cell death have also
been implicated.
Those gene alterations are produced by
genotoxic substances, either environmental
xenobiotics entering the body or autobi-
otics generated inside the body, or even
through an enhanced frequency of cell
proliferation that increases the chance of
incorrect replication ofgenetic materials.
Cells acquire a growth advantage
because of initial genetic alterations that
accelerate passage through the cell cycle; in
the course of carcinogenesis, during the
multistep conversion of a normal cell to a
malignant one, mutations accumulate suc-
cessively. The thus formed final malignant
cell eventually dominates. In other words,
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cancer masses are due to successive mono-
clonal growths, in each case originally
derived from a single cell.
Exogenous Food
Mutagens/Carcinogens
Food mutagens are major xenobiotic
genotoxic substances. They include, as typ-
ical examples, aflatoxin B1 from Aspergillus
flavus, nitrosamines in fermented foods,
polycyclic aromatic hydrocarbons in heated
foods, heterocyclic amines in heated meat
and fish, and pyrrolizidine alkaloids from
plants (1-3). Most ofthem are metaboli-
cally oxidized by cytochrome P450s and
then esterified to ultimately reactive forms
to produce DNA adducts through elec-
trophile and nucleophile reactions as
documented by Miller and Miller (4).
Autobiotic
Mutagens/Carcinogens
Endogenous genotoxic substances have also
attracted much attention. They are not
directly food related but can act in collabo-
ration with exogenous food mutagens to
cause accumulation of genetic alterations
in cells.
Typical examples are active oxygen
molecular species which can inflict various
types ofoxidative damage ofDNA, a typi-
cal example being the 8-hydroxyguanine
that was first discovered by Kasai and
Nishimura (5). Nitrite is considered as a
precursor for the formation of nitroso
compounds under acidic conditions, and
food additives and vegetables are known to
be sources of nitrite/nitrate (6). It is well
documented that N-nitrosamines are
formed from the reaction of nitrite with
secondary amines under acidic conditions.
Many phenol and indole derivatives pre-
sent in our environment have also been
demonstrated to give rise to mutagenic and
carcinogenic nitrosated compounds (7).
Products from phenolic compounds and
nitrite are diazo derivatives, and those from
indole compounds and nitrite are N-1
and/or C-3 nitrosated products. However,
recent findings indicate that nitric oxide
synthase, both constitutively expressed in
organs such as the liver and inducible in
macrophages, produces nitric oxide from
L-arginine. This nitric oxide is involved in
endogenous formation of nitroso com-
pounds (8,9). Nitric oxide is also a potent
deaminating agent for 5-methylcytosine
residues of DNA, converting them to
thymine residues (10). Thus, CG pairs at
CpG sites change to TA pairs.
Inflammation most likely contributes
to the induction of nitric oxide synthase,
providing one reason for the fact that
chronic gastritis, ulcerative colitis, chronic
hepatitis, and chronic pancreatitis are all
carcinogenesis-prone conditions. Further-
more, any chronic mechanical stimuli
causing chronic tissue damage, such as
inappropriate tooth prostheses and calculi
in the gallbladder, urinary pelvis, and blad-
der, enhance epithelial cell proliferation
through regenerative processes.
Mutagens/Carcinogens
in Food
OrdinaryConstituents in FoodActing
as Conditional Carcinogenic Factors
Areas where people ingest more sodium
chloride show an elevated incidence ofgas-
tric cancers (11). Such salt intake causes
mucous membrane damage to the stom-
ach, as evidenced by the existence of mal-
ondialdehyde in extracts ofgastric mucous
membranes after sodium chloride adminis-
tration (12). Malondialdehyde, a product
oflipid peroxidation that could be gener-
ated by damage of cell membranes, has
previously been reported to be mutagenic
to bacteria and mammalian cells and
carcinogenic to rats (13-15). Recently,
malondialdehyde-deoxyguanosine adducts
were detected in human liver (16). It is
therefore likely that sodium chloride-lipid
peroxidation-malondialdehyde-mutation
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scenarios play a role in carcinogenesis in
the stomach.
Helicobactor pylori infection in the
mucosa ofthe stomach results in gastritis,
which may increase formation of nitric
oxide (17) as well other proliferative
stimuli. It is therefore a factor that might
facilitate accumulation ofgene alterations.
Antimutagenic andAnticarcinogenic
Factors inFood
There are many substances in food that can
counteract mutagenic and carcinogenic
processes. Testing ofvegetables and fruits
for mutagenic activity with Salmonella
typhimurium strains have indicated that
flavonoids account for a large part ofthe
activity (18,19). The most commonly
found flavonoids are quercetin and its gly-
coside, rutin; however, quercetin exerts no
carcinogenicity in mice, rats, and hamsters
in long-term animal feeding experiments
(20-23). The experimental results of the
National Toxicological Program in F344
rats only demonstrated formation of renal
tubular cell adenomas in males (24), and
in this case a2u-globulin nephropathy may
have played some role. Thus, the data are
not regarded as unequivocal evidence of
anycarcinogenicity for quercetin.
On the contrary, many papers have
suggested that flavonoid and isoflavonoid
compounds should be regarded as anticar-
cinogens in nature (25-27). One related
mechanism could be inhibition of the
arachidonic acid cascade, especially at the
lipoxygenase step (25). Some flavonoids
may also function as active oxygen scav-
engers. Furthermore, there are many other
polyphenolic compounds showing anticar-
cinogenic activity in plants, including epi-
gallocatechin gallate from tea leaves and
curcumin from the turmeric plant, Curcuma
longa, ofthe ginger family (28-31).
(3-Carotene in vegetables and fruits is
an effective cancer preventive agent,
especially for carcinomas arising from squa-
mous epithelium and squamous metaplas-
tic lesions (32). However, an adverse effect
of (-carotene was reported in an interven-
tion study on lung cancer development
among smokers (33). (-Carotene is under-
stood to be converted to vitamin A. a-
Carotene is also convertible to vitamin A,
but its pro-vitamin A potency is only half
that of (-carotene; therefore, it was. not
expected to be so effective for cancer pre-
vention. However, recently it was demon-
strated that a-carotene is in fact more
efficient than (3-carotene in a mouse liver
carcinogenesis experiment and in two-step
carcinogenesis experiments focusing on
mouse lung and skin (34).
Fish oils are rich in polyunsaturated
o3 fatty acids, including eicosapentaenoic
acid and docosahexaenoic acid, which
can suppress dimethylhydrazine and azoxy-
methane-induced aberrant crypt foci
and cancer in the colon of rats (35,36).
Docosahexaenoic acid is an inhibitor of
prostaglandin synthesis. Nonsteroidal anti-
inflammatory agents such as indomethacin,
sulindac, and aspirin, which also inhibit
prostaglandin synthesis, have similarly been
reported to reduce development of colon
cancer in animals (37-39). Thus, the
mechanism underlying the inhibitory
effects of W3 fatty acids on colon cancer
development may be the same as that of
nonsteroidal anti-inflammatory agents.
Another factor in food relevant to can-
cer prevention is fibers from vegetables,
fruits, and grains. They dilute concentra-
tion of mutagens and carcinogens in the
intestinal tract due to the increased mass
and make the passage ofintestinal material
much faster so that uptake of included
mutagens and carcinogens may be reduced.
These characteristics are consistent with
data indicating that a high risk of colon
cancer is associated with a low intake of
dietary fiber (40).
HeterocyclicAmines: ANewSeries
ofMutagens/Carcinogens
in HeatedFoods
It has been well documented that cigarette
smoke condensate contains a variety of
mutagens and carcinogens. Our group
therefore expected that smoke derived
from burning foodstuffs might similarly
contain mutagens and carcinogens. In fact
smoke condensate obtained by broiling
fish showed mutagenicity to Salmonella
typhimurium TA98 with a metabolic acti-
vation system (41). It was also proved
that charred parts ofmeat and fish, cooked
under ordinary conditions, exert much
higher mutagenic activity to TA98 after
metabolic activation (41). By monitoring
the mutagenic activity, the actual muta-
genic substances could be purified from
cooked food as well as from pyrolyzed
amino acids and proteins. Up to the pres-
ent, a total of23 heterocyclic amines have
been isolated as mutagens, and structures
of 19 ofthem were determined, as shown
in Figure 1 (2,42). All the compounds
except one were newly registered chemicals.
Among them, most heterocyclic amines
were found by our group, while a-carbo-
line compounds were isolated by Yoshida
et al. (43) and 2-amino-1-methyl-6-phen-
ylimidazo[4,5-b]pyridine (PhIP) and 2-
amino-3-methylimidazo[4,5-f]quinoxalin
e (IQx) were isolated by Felton et al. (44)
and Becher et al. (45). Moreover, 10 of
these compounds have subsequently been
chemically synthesized on a large scale to
allow long-term carcinogenesis experiments
to be performed. All ofthe 10 compounds
were proven to be carcinogenic in rats or
mice (2,42). They are metabolically acti-
vated mainly by cytochrome P450IA2 with
conversion ofan amino group to a hydroxy-
amino group and further esterified to give
the ultimate forms that produce DNA
adducts. The series ofheterocyclic amines
can be divided into two groups: the 2-
amino-3-methylimidazo[4,5-f]quinoline
(IQ)-type heterocyclic amines and non-IQ-
type heterocyclic amines. IQ-type-hetero-
cyclic amines have a 2-aminoimidazole
moiety as a common structure and are
formed by heating mixtures of creatine,
amino acids, and sugars. Non-IQ-type het-
erocyclic amines contain a 2-aminopyri-
dine moiety as a common structure and are
produced by heating amino acids such as
L-tryptophan and L-glutamic acid. In rou-
tinely cooked meat and fish, the former
type ofheterocyclic amines, amino imida-
zoquinolines, amino imidazoquinoxalines,
and amino imidazopyridines account for
the major portion ofthe mutagenicity.
Based on quantitative data on amounts
ofheterocyclic amines in cooked food, cig-
arette smoke, and urine samples from
healthy volunteers, daily intakes ofhetero-
cyclic amines have been estimated. For
example, the daily levels of exposure to
2-amino-3,8-dimethylimidazo [4,5 -
f]quinoxaline (MeIQx) and 2-amino-i-
methyl-6-phenylimidazo[4,5-b]pyridine
(PhIP) were calculated to be less than
1/800 of their tumorigenic dose rate 50
(TD50) values, obtained from studies of
their carcinogenicity in mice and rats.
Riskof Mutagens andCardnogens
inFoodand CancerPrevention
Diet is known to be an important factor
determining cancer risk together with
other lifestyle parameters including ciga-
rette smoking, alcohol intake, and physical
exercise, as well as infection and disease. As
described in the previous section, diet may
be directly involved in carcinogenicity
through damage to DNA. Human cells are
continuously being exposed to mutagenic
substances and conditions yielding DNA
damage; it is clear that mutations resulting
in genomic instability, including DNA
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Figure 1. Structures of mutagenic and carcinogenic heterocyclic amines. Abbreviations: Trp-P-1, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole; Trp-P-2, 3-amino-i-methyl-5H-
pyrido[4,3-blindole; Glu-P-1, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole; Glu-P-2, 2-aminodipyrido[1,2-a:3',2'-d]imidazole; Phe-P-1, 2-amino-5-phenylpyridine; Orn-P-1,
4-amino-6-methyl-1H-2,5,10,1Ob-tetraazafluoranthene; AcaC, 2-amino-9H-pyrido[2,3-b]indole; MeAaC, 2-amino-3-methyl-9H-pyrido[2,3-blindole; IQ, 2-amino-3-methylimi-
dazo[4,5-f]quinoline; MelQ, 2-amino-3,4-dimethylimidazo[4,5-flquinoline; lQx, 2-amino-3-methylimidazo[4,5-f]quinoxaline; MelQx, 2-amino-3,8-dimethylimidazo[4,5-f]-
quinoxaline; 4,8-DiMelQx, 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline; 7,8-DiMelQx, 2-amino-3,7,8-trimethylimidazo[4,5-f]quinoxaline; PhIP,
2-amino-i-methyl-6-phenylimidazo[4,5-b]pyridine; 4'-OH-PhIP, 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo[4,5-b]pyridine; Cre-P-1, 4-amino-1,6-dimethyl-2-methylamino-
1H,6H-pyrrolo[3,4-f]benzimidazole-5,7-dione; 4-CH20H-8-MelQx, 2-amino-4-hydroxymethyl-3,8-dimethylimidazo[4,5-f]quinoxaline; 7,9-DiMelgQx, 2-amino-1,7,9-trimethylimi-
dazo[4,5-g]quinoxaline. The following ten compounds have been proven to be carcinogenic: Trp-P-1, Trp-P-2, Glu-P-1, Glu-P-2, Aa C, MeAaC, 10, MelQ, MelOx, PhIP.
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Figure 2. Scheme for genomic instability in carcino-
genesis. Arrows indicate the gene alteration related to
genomic instability. The light gray represents nonma-
lignancy and the dark gray represents full malignancy.
repair deficiency, may have a pronounced
effect on accumulation of genetic alter-
ations as shown in Figure 2 (46,47). On
the other hand, the diet also contains
numerous antimutagenic and anticarcino-
genic factors. Therefore, the risk of cancer
development in man from food-derived
mutagens and carcinogens is hard to
estimate only from the basis ofdata ofdaily
human exposure and oflong-term animal
experiments conducted with maximum
tolerated doses.
Furthermore, it is becoming increas-
ingly evident that the human cancers are
not produced by a single carcinogenic
agent but rather are the result of many
carcinogenic compounds, each acting at
very low exposure levels. Certain types of
malignancies have a known etiology such
as adult T-cell leukemia, which is initiated
by infection with the adult T-cell leukemia
virus through breast-feeding of newborns.
Even in this case, however, the onset of
disease only occurs when the affected
individuals reach 30 to 60 years of age.
Mathematical analysis shows that several
additional events must occur during the
long latent period (48). Viral infection is
thus in itselfnot sufficient for the complete
disease process. This is also true for the
case of hepatitis B or hepatitis C virus
infection and development ofhepatocellu-
lar carcinomas during the course ofwhich
genetic alterations accumulate. Susceptibility
to food-derived mutagens and carcinogens
might be increased when cell turnover is
accelerated. Therefore, the mathematical
approach is less easily applicable to the
general population among whom there are
different backgrounds on the presence of
cells having genetic alterations.
Nevertheless, we can say that human
beings are exposed synchronously and het-
erochronously to various mutagenic and
carcinogenic factors and that these could
be responsible for the genetic alterations
found in human cancer cells. The pitfall
that scientists working on certain factors
tend to consider is that they think their
compounds are more important than oth-
ers for production ofcancers. The real situ-
ation probably is that exposure to the
agents on which scientists themselves are
working might correspond to the tip ofan
iceberg floating on the sea. The submerged
unseen portion clearly is the major prob-
lem, namely exposures to other agents. We
can therefore conclude that any exposure
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to food mutagens and carcinogens should
be decreased as far as possible. In some
cases, from the viewpoints ofculture, tradi-
tion, and economics, it may be better
accept the presence of tiny amounts of
mutagens and carcinogens in food. The
same principle in reverse, stands for
antimutagenic/anticarcinogenic factors.
Various factors that belong to entirely dif-
ferent categories may be expected to collab-
orate in cancer prevention. Again it is
recommended that appropriate measures
be taken to optimize our exposure to
anticarcinogenic/antimutagenic factors.
This approach to cancer prevention has the
twin advantages of being both pragmatic
and achievable.
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